The cytokine profile observed in this study—elevated plasma levels of IL-6 and IL-10, particularly in AD patients, and elevated plasma levels of IL-17A, particularly in SC patients—corroborates the results of a previous study carried out by our research group, which analyzed a cohort of 118 SC patients, 130 patients hospitalized for AD cirrhosis, and 30 healthy controls45. The gene discussed is IL17A; the disease is Alzheimer disease.